Literature DB >> 9933201

Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey.

S Morgan1, H Smith, I Simpson, G S Liddiard, H Raphael, R M Pickering, D Mant.   

Abstract

OBJECTIVE: To assess the prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in the general practice setting by echocardiographic assessment of ventricular function.
DESIGN: Cross sectional survey.
SETTING: Four centre general practice in Poole, Dorset.
SUBJECTS: 817 elderly patients aged 70-84 years. MAIN OUTCOMES: Echocardiographic assessment of left ventricular systolic function including measurement of ejection fraction by biplane summation method where possible, clinical symptoms, and signs of left ventricular dysfunction.
RESULTS: The overall prevalence of left ventricular systolic dysfunction was 7.5% (95% confidence interval 5.8% to 9.5%); mild dysfunction (5.0%) was considerably more prevalent than moderate (1.6%) or severe dysfunction (0.7%). Measurement of ejection fraction was possible in 82% of patients (n=667): in patients categorised as having mild, moderate, or severe dysfunction, the mean ejection fraction was 48% (SD 12.0), 38% (8.1), and 26% (7.9) respectively. At all ages the prevalence was much higher in men than in women (odds ratio 5.1, 95% confidence interval 2.6 to 10.1). No clinical symptom or sign was both sensitive and specific. In around half the patients with ventricular dysfunction (52%, 32/61) heart failure had not been previously diagnosed.
CONCLUSIONS: Unrecognised left ventricular dysfunction is a common problem in elderly patients in the general practice setting. Appropriate treatment with angiotensin converting enzyme inhibitors has the potential to reduce hospitalisation and mortality in these patients, but diagnosis should not be based on clinical history and examination alone. Screening is feasible in general practice, but it should not be implemented until the optimum method of identifying left ventricular dysfunction is clarified, and the cost effectiveness of screening has been shown.

Entities:  

Mesh:

Year:  1999        PMID: 9933201      PMCID: PMC27725          DOI: 10.1136/bmj.318.7180.368

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  22 in total

Review 1.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

2.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Prevalence and mortality rate of congestive heart failure in the United States.

Authors:  D D Schocken; M I Arrieta; P E Leaverton; E A Ross
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

5.  Validity of clinical diagnosis of heart failure in primary health care.

Authors:  J Remes; H Miettinen; A Reunanen; K Pyörälä
Journal:  Eur Heart J       Date:  1991-03       Impact factor: 29.983

6.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

7.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

8.  Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence.

Authors:  J K Ghali; R Cooper; E Ford
Journal:  Arch Intern Med       Date:  1990-04

9.  Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction.

Authors:  A F Amico; G S Lichtenberg; S A Reisner; C K Stone; R G Schwartz; R S Meltzer
Journal:  Am Heart J       Date:  1989-12       Impact factor: 4.749

10.  Prevalence of heart failure in three general practices in north west London.

Authors:  J Parameshwar; M M Shackell; A Richardson; P A Poole-Wilson; G C Sutton
Journal:  Br J Gen Pract       Date:  1992-07       Impact factor: 5.386

View more
  34 in total

1.  The barriers to effective management of heart failure in general practice.

Authors:  J A Hickling; I Nazareth; S Rogers
Journal:  Br J Gen Pract       Date:  2001-08       Impact factor: 5.386

2.  Left ventricular dysfunction among elderly patients in general practice. Electrocardiograms are useful in these patients...

Authors:  S Talwar; P F Downie
Journal:  BMJ       Date:  1999-05-29

Review 3.  Screening for left ventricular dysfunction: a step too far?

Authors:  T A McDonagh
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

4.  Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care.

Authors:  A Niroshan Siriwardena; Aly Rashid; Mark R D Johnson; Michael E Dewey
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

5.  Clinical burden and health service challenges of chronic heart failure.

Authors:  F D Richard Hobbs
Journal:  Br J Gen Pract       Date:  2010-08       Impact factor: 5.386

6.  Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study.

Authors:  Jérôme R Lechien; Camille Finck; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-17       Impact factor: 2.503

Review 7.  Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms.

Authors:  D Sumukadas; M D Witham; A D Struthers; M E T McMurdo
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

8.  Cardiopulmonary assessment: is improvement needed?

Authors:  Joseph M Van De Water; Martin L Dalton; David C Parish; Robert L Vogel; John C Beatty; Said O Adeniyi
Journal:  World J Surg       Date:  2005       Impact factor: 3.352

9.  Summary of scientific evidence.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  2002-02

10.  Heart failure and the aging population: an increasing burden in the 21st century?

Authors:  S Stewart; K MacIntyre; S Capewell; J J V McMurray
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.